Free Trial

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 23,640 Shares of Synopsys, Inc. (NASDAQ:SNPS)

Synopsys logo with Computer and Technology background

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC decreased its stake in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 1.5% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 1,510,830 shares of the semiconductor company's stock after selling 23,640 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 0.98% of Synopsys worth $733,296,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in SNPS. HB Wealth Management LLC increased its holdings in shares of Synopsys by 2.0% during the 4th quarter. HB Wealth Management LLC now owns 3,172 shares of the semiconductor company's stock worth $1,540,000 after purchasing an additional 63 shares during the period. Aaron Wealth Advisors LLC boosted its position in shares of Synopsys by 27.9% during the 4th quarter. Aaron Wealth Advisors LLC now owns 647 shares of the semiconductor company's stock valued at $314,000 after acquiring an additional 141 shares in the last quarter. Diversify Wealth Management LLC boosted its position in shares of Synopsys by 221.2% during the 4th quarter. Diversify Wealth Management LLC now owns 2,133 shares of the semiconductor company's stock valued at $1,051,000 after acquiring an additional 1,469 shares in the last quarter. Diversify Advisory Services LLC acquired a new stake in shares of Synopsys during the 4th quarter valued at about $877,000. Finally, Aurora Investment Managers LLC. boosted its position in shares of Synopsys by 2.3% during the 4th quarter. Aurora Investment Managers LLC. now owns 1,397 shares of the semiconductor company's stock valued at $678,000 after acquiring an additional 32 shares in the last quarter. Institutional investors own 85.47% of the company's stock.

Insider Transactions at Synopsys

In other news, CEO Sassine Ghazi sold 11,366 shares of the company's stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $463.75, for a total transaction of $5,270,982.50. Following the transaction, the chief executive officer now directly owns 70,922 shares in the company, valued at approximately $32,890,077.50. This represents a 13.81% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Geus Aart De sold 15,705 shares of the company's stock in a transaction that occurred on Thursday, March 6th. The stock was sold at an average price of $444.42, for a total transaction of $6,979,616.10. Following the transaction, the insider now owns 116,671 shares in the company, valued at $51,850,925.82. The trade was a 11.86% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.62% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on SNPS shares. Needham & Company LLC reiterated a "buy" rating and set a $650.00 target price on shares of Synopsys in a research report on Thursday, February 27th. Piper Sandler decreased their target price on shares of Synopsys from $655.00 to $653.00 and set an "overweight" rating on the stock in a research report on Thursday, February 27th. Stifel Nicolaus set a $550.00 target price on shares of Synopsys in a research report on Monday, April 28th. Morgan Stanley decreased their target price on shares of Synopsys from $625.00 to $590.00 and set an "overweight" rating on the stock in a research report on Monday, February 24th. Finally, Bank of America decreased their target price on shares of Synopsys from $630.00 to $560.00 and set a "buy" rating on the stock in a research report on Wednesday, April 16th. One investment analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $614.86.

Check Out Our Latest Report on Synopsys

Synopsys Stock Down 0.1%

NASDAQ:SNPS opened at $515.61 on Wednesday. The firm has a market cap of $79.72 billion, a PE ratio of 35.51, a price-to-earnings-growth ratio of 3.23 and a beta of 1.16. Synopsys, Inc. has a 12 month low of $365.74 and a 12 month high of $624.80. The company's 50-day moving average price is $447.85 and its two-hundred day moving average price is $489.13.

Synopsys Company Profile

(Free Report)

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

Read More

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Synopsys Right Now?

Before you consider Synopsys, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.

While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The Hottest AI Stock You Haven’t Bought Yet
This $13 Trillion Energy Breakthrough Will Make Millionaires
Magnificent 7 Stocks Shift Toward Stability and Selective Growth

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines